US2003212318A1PendingUtilityA1
Process for producing an implantable apparatus comprising a biomedical device coated with crosslinked TPU
Priority: Nov 18, 1998Filed: Feb 26, 2003Published: Nov 13, 2003
Est. expiryNov 18, 2018(expired)· nominal 20-yr term from priority
Inventors:Alan M. Zamore
A61L 27/34
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for producing increased resistance to biodegradability is provided for biomedical devices subject to in vivo implantation. Among the steps required to produce such resistance are the application of a thermoplastic polyurethane coating to the device to provide a coating, and the subsequent crosslinking of the thermoplastic polyurethane coating through the application of radiation of a sufficient intensity and duration to convert said thermoplastic polyurethane coating to a thermoset coating possessing the attribute of increased biostability.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for manufacturing a coated biomedical device exhibiting enhanced in vivo biostability comprising:
(a) applying a radiation cross-linkable thermoplastic polyurethane coating to the device in order to insulate said device from biological elements; and (b) irradiating said thermoplastic polyurethane coating to form a thermoset coating through the application of radiation of a sufficient intensity and duration to cause said thermoplastic polyurethane coating to convert to a thermoset coating, said thermoset coating exhibiting enhanced in vivo biostability relative to said thermoplastic coating.
2 . The method of claim 1 including the additional step of incorporating a crosslinking agent predominantly free of hydroxyl groups and predominantly nonincorporable into the thermoplastic polyurethane coating prior to irradiation.
3 . The method of claim 2 wherein the crosslinking agent comprises an allylic monomer.
4 . The method of claim 2 wherein the crosslinking agent comprises an acrylic or methacrylic monomer.
5 . The method of claim 2 wherein the crosslinking agent comprises meta-phenylene dimaleimide.
6 . The method of claim 1 wherein step(b) is effected simultaneously with, or after, step(a).
7 . The method of claim 1 wherein the biomedical device comprises an electrically conductive wire.
8 . The method of claim 1 wherein the polyurethane coating comprises an aromatic thermoplastic polyurethane.
9 . The method of claim 1 wherein the polyurethane coating comprises an aliphatic thermoplastic polyurethane.
10 . The method of claim 1 wherein the polyurethane coating comprises a mixture of differing amounts of aromatic and aliphatic polyurethanes.
11 . The method of claim 1 wherein the polyurethane coating comprises differing amounts of thermoplastic polyurethane and other polymeric materials or a copolymer of TPU.
12 . The method of claim 1 wherein the polyurethane coating is crosslinked utilizing UV radiation.
13 . The method of claim 1 wherein the polyurethane coating is crosslinked utilizing electron beam irradiation.
14 . The method of claim 1 wherein the polyurethane coating is crosslinked utilizing gamma radiation.
15 . The method of claim 2 wherein the polyurethane coating is crosslinked utilizing electron beam irradiation, gamma or LN radiation.
16 . An apparatus for use in in vivo implantation comprising a biomedical device, at least a portion of which is encapsulated in a coating to provide an encapsulated device, said encapsulated device being encapsulated with a cross-linked thermoplastic polyurethane coating providing enhanced biostability as compared to a biomedical device free of crosslinked thermoplastic polyurethane coating.
17 . The coated biomedical device produced by the method of claim 1.Join the waitlist — get patent alerts
Track US2003212318A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.